The ChatGPT founder invests $180M to extend life.
We all age. We thought so, at least before tech CEOs began investing billions in start-ups that were researching anti-aging and long-term health. Sam Altman, of ChatGPT fame, was the $180 million mysterious investor who kicked off Retro Sciences’ research into the topic.
Retro Biosciences, a biotech company in Silicon Valley has set out to add 10 years to the human lifespan. They plan to achieve this by combining their collective knowledge on cellular reprogramming and autophagy with plasma-inspired therapies. They have a secret weapon. They are going to use machine-learning-based computational biology and lab automation to help with the project. OpenAI’s CEO must have been interested in the project if he invested a large portion of his liquid assets. It’s not the first time a tech billionaire has invested in anti-aging and longevity.
Jeff Bezos has invested in Alton Labs as well, a company that focuses on cellular rejuvenation. Will life extension be a lucrative industry in the near future or are Silicon Valley eccentrics simply fighting a uphill battle against mortality and human nature to win? We may find out sooner than expected.
#chatgpt #samaltman.
Join our YouTube channel by clicking here: https://bit.ly/3asNo2n.
Find us on Instagram: https://bit.ly/3PM21xW
Find us on Facebook: https://bit.ly/3t2Huvb.
Find us on Twitter: https://bit.ly/3wQfXzA
Find us on TikTok: https://bit.ly/3wNsBOu.
Get the latest stories: https://interestingengineering.com/
Source:
